Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Small Cell Lung Cancer, Oligometastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05837052
What this trial is testing

A Phase II Trial to Evaluate the Efficiency and Safety of Serplulimab Plus Chemotherapy as Conversion Therapy in NSCLC

Who this might be right for
Unresectable Lung Non-Small Cell Carcinoma
Zhejiang University 49
Testing effectiveness (Phase 2)Looking for participantsNCT04375904
What this trial is testing

'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung)

Who this might be right for
NSCLC/Oligometastatic Cancer (Single Lung Lesion)
Cancer Trials Ireland 68
Testing effectiveness (Phase 2)Looking for participantsNCT05501665
What this trial is testing

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage III Lung Cancer
Vanderbilt-Ingram Cancer Center 25
Testing effectiveness (Phase 2)Looking for participantsNCT05277844
What this trial is testing

Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC

Who this might be right for
Oligometastatic DiseaseNon-small Cell Lung CancerDriver Mutation
Tata Memorial Hospital 106
Testing effectiveness (Phase 2)Study completedNCT02316002
What this trial is testing

Phase II Study of Pembrolizumab After Curative Intent Treatment for Oligometastatic Non-Small Cell Lung Cancer

Who this might be right for
Oligometastatic Non-small Cell Lung Cancer (NSCLC)
Abramson Cancer Center at Penn Medicine 51
Not applicableStudy completedNCT02450591
What this trial is testing

Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations

Who this might be right for
Oligometastatic Lung Adenocarcinoma
Memorial Sloan Kettering Cancer Center 4
Not applicableUnknownNCT03489616
What this trial is testing

Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Shandong Cancer Hospital and Institute 45
Not applicableLooking for participantsNCT04926584
What this trial is testing

Prospective Trial of Induction Immunotherapy in Locally Advanced or Oligometastatic NSCLC Without a Primary Curative Option

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Klinikum Esslingen 50
Testing effectiveness (Phase 2)UnknownNCT05472467
What this trial is testing

Camrelizumab Combination With SBRT and Concurrent Chemotherapy Treated Stage IV Oligometastatic Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Sichuan Cancer Hospital and Research Institute 35